List of Tables
    Table 1. Devic's Disease Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Devic's Disease Drug Market Trends
    Table 3. Devic's Disease Drug Market Drivers
    Table 4. Devic's Disease Drug Market Challenges
    Table 5. Devic's Disease Drug Market Restraints
    Table 6. Global Devic's Disease Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Devic's Disease Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Devic's Disease Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Devic's Disease Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Devic's Disease Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Devic's Disease Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Devic's Disease Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Devic's Disease Drug Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Devic's Disease Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Devic's Disease Drug Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Devic's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Devic's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Devic's Disease Drug as of 2021)
    Table 18. Top Players of Devic's Disease Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Devic's Disease Drug Product Type
    Table 20. Date of International Manufacturers Enter into Devic's Disease Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Devic's Disease Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Devic's Disease Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Devic's Disease Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Devic's Disease Drug Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Devic's Disease Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Devic's Disease Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Devic's Disease Drug Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Devic's Disease Drug Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Devic's Disease Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Devic's Disease Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Devic's Disease Drug Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Devic's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Devic's Disease Drug Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Devic's Disease Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Devic's Disease Drug Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Devic's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Devic's Disease Drug Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Devic's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Devic's Disease Drug Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Devic's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Pfizer Devic's Disease Drug Product
    Table 46. Pfizer Recent Development
    Table 47. Fresenius Corporation Information
    Table 48. Fresenius Description and Business Overview
    Table 49. Fresenius Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Fresenius Product
    Table 51. Fresenius Recent Development
    Table 52. TEVA Corporation Information
    Table 53. TEVA Description and Business Overview
    Table 54. TEVA Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. TEVA Product
    Table 56. TEVA Recent Development
    Table 57. Sandoz Corporation Information
    Table 58. Sandoz Description and Business Overview
    Table 59. Sandoz Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Sandoz Product
    Table 61. Sandoz Recent Development
    Table 62. Intas Corporation Information
    Table 63. Intas Description and Business Overview
    Table 64. Intas Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Intas Product
    Table 66. Intas Recent Development
    Table 67. Gyjtrs Corporation Information
    Table 68. Gyjtrs Description and Business Overview
    Table 69. Gyjtrs Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Gyjtrs Product
    Table 71. Gyjtrs Recent Development
    Table 72. Nang Kuang Corporation Information
    Table 73. Nang Kuang Description and Business Overview
    Table 74. Nang Kuang Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Nang Kuang Product
    Table 76. Nang Kuang Recent Development
    Table 77. Tianjin Kingyork Corporation Information
    Table 78. Tianjin Kingyork Description and Business Overview
    Table 79. Tianjin Kingyork Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Tianjin Kingyork Product
    Table 81. Tianjin Kingyork Recent Development
    Table 82. Baxter Corporation Information
    Table 83. Baxter Description and Business Overview
    Table 84. Baxter Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Baxter Product
    Table 86. Baxter Recent Development
    Table 87. CSL Corporation Information
    Table 88. CSL Description and Business Overview
    Table 89. CSL Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. CSL Product
    Table 91. CSL Recent Development
    Table 92. Grifols Corporation Information
    Table 93. Grifols Description and Business Overview
    Table 94. Grifols Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Grifols Product
    Table 96. Grifols Recent Development
    Table 97. Octapharma Corporation Information
    Table 98. Octapharma Description and Business Overview
    Table 99. Octapharma Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Octapharma Product
    Table 101. Octapharma Recent Development
    Table 102. CBOP Corporation Information
    Table 103. CBOP Description and Business Overview
    Table 104. CBOP Devic's Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. CBOP Product
    Table 106. CBOP Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Devic's Disease Drug Customers List
    Table 110. Devic's Disease Drug Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Devic's Disease Drug Product Picture
    Figure 2. Global Devic's Disease Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Devic's Disease Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Devic's Disease Drug Sales 2017-2028 (K MT)
    Figure 5. United States Devic's Disease Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Devic's Disease Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Devic's Disease Drug Sales 2017-2028 (K MT)
    Figure 8. United States Devic's Disease Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Devic's Disease Drug Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Devic's Disease Drug Report Years Considered
    Figure 11. Product Picture of Glucocorticoids
    Figure 12. Product Picture of Immunoglobulin
    Figure 13. Product Picture of Other
    Figure 14. Global Devic's Disease Drug Market Share by Type in 2022 & 2028
    Figure 15. Global Devic's Disease Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Devic's Disease Drug Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Devic's Disease Drug Sales by Type (2017-2028) & (K MT)
    Figure 18. Global Devic's Disease Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Devic's Disease Drug Price by Type (2017-2028) & (USD/MT)
    Figure 20. United States Devic's Disease Drug Market Share by Type in 2022 & 2028
    Figure 21. United States Devic's Disease Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Devic's Disease Drug Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Devic's Disease Drug Sales by Type (2017-2028) & (K MT)
    Figure 24. United States Devic's Disease Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Devic's Disease Drug Price by Type (2017-2028) & (USD/MT)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Others
    Figure 29. Global Devic's Disease Drug Market Share by Application in 2022 & 2028
    Figure 30. Global Devic's Disease Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Devic's Disease Drug Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Devic's Disease Drug Sales by Application (2017-2028) & (K MT)
    Figure 33. Global Devic's Disease Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Devic's Disease Drug Price by Application (2017-2028) & (USD/MT)
    Figure 35. United States Devic's Disease Drug Market Share by Application in 2022 & 2028
    Figure 36. United States Devic's Disease Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Devic's Disease Drug Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Devic's Disease Drug Sales by Application (2017-2028) & (K MT)
    Figure 39. United States Devic's Disease Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Devic's Disease Drug Price by Application (2017-2028) & (USD/MT)
    Figure 41. North America Devic's Disease Drug Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 42. North America Devic's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Devic's Disease Drug Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 46. Europe Devic's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Devic's Disease Drug Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 53. Asia-Pacific Devic's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Devic's Disease Drug Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 65. Latin America Devic's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Devic's Disease Drug Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 70. Middle East & Africa Devic's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Devic's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Devic's Disease Drug Value Chain
    Figure 75. Devic's Disease Drug Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed